Arun Shahi MD,MPH, ECMO 🇳🇵 (@drarunshahi1) 's Twitter Profile
Arun Shahi MD,MPH, ECMO 🇳🇵

@drarunshahi1

Consultant Of Medical Oncology

ID: 1397458764186349568

calendar_today26-05-2021 07:45:21

65 Tweet

190 Takipçi

336 Takip Edilen

Arun Shahi MD,MPH, ECMO 🇳🇵 (@drarunshahi1) 's Twitter Profile Photo
Arun Shahi MD,MPH, ECMO 🇳🇵
@drarunshahi1

a year ago

Very timely approval with the four year data out.FDA Approves Ribociclib With an Aromatase Inhibitor in Early Breast Cancer. This is for stage 2 and 3 breast cancer at high risk for recurrence, that includes node negative disease. This is a big win!

Very timely approval with the four year data out.FDA Approves Ribociclib With an Aromatase Inhibitor in Early Breast Cancer. This is for stage 2 and 3 breast cancer at high risk for recurrence, that includes node negative disease. This is a big win!